XNAS 16 Oct, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mr. Andrew Enrietti | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2026 | 999 | 234,879 (0%) | 0% | 0 | Common Stock | |
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.23 per share. | 15 Aug 2026 | 10,931 | 233,880 (0%) | 0% | 16.2 | 177,410 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2026 | 25,134 | 244,811 (0%) | 0% | 0 | Common Stock | |
| Mr. Andrew Enrietti | See Remarks | 15 Aug 2026 | 998 | 1,997 | - | - | Dividend Equivalent Units | ||
| Mr. Andrew Enrietti | See Remarks | 15 Aug 2026 | 25,134 | 50,267 | - | - | Restricted Stock Units | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.23 per share. | 15 Aug 2026 | 435 | 234,444 (0%) | 0% | 16.2 | 7,060 | Common Stock |
| Mr. David S. Simmons | Director | 30 Jun 2026 | 2,362 | 2,362 | - | - | Deferred Stock Units | ||
| Mr. Leo Groothuis | Director | 30 Jun 2026 | 2,756 | 2,756 | - | - | Deferred Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 25 Jun 2026 | 50,076 | 316,212 (0%) | 0% | 16.2 | 809,784 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2026 | 3,644 | 108,752 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 15 Apr 2026 | 3,643 | 0 | - | - | Dividend Equivalent Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2026 | 39,344 | 122,558 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share. | 15 Apr 2026 | 17,450 | 105,108 (0%) | 0% | 13.9 | 241,857 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 15 Apr 2026 | 39,344 | 0 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share. | 15 Apr 2026 | 1,617 | 107,135 (0%) | 0% | 13.9 | 22,412 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 23 Mar 2026 | 21,350 | 366,288 (0%) | 0% | 13.3 | 283,539 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 23 Mar 2026 | 21,350 | 366,288 (0%) | 0% | 13.3 | 283,539 | - |
| Ms. Elisha W. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 62,667 (0%) | 0% | 0 | Common Stock | |
| Ms. Elisha W. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 61,492 (0%) | 0% | 0 | Common Stock | |
| Ms. Elisha W. Finney | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Ms. Elisha W. Finney | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Elisha W. Finney | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 161,257 (0%) | 0% | 0 | Common Stock | |
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 160,082 (0%) | 0% | 0 | Common Stock | |
| Mr. James M. Kilts | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Wyllie Don Cornwell | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 110,869 (0%) | 0% | 0 | Common Stock | |
| Mr. Wyllie Don Cornwell | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 112,044 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Mark W. Parrish | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 164,055 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 165,230 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 6,182 | 1,331,759 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 124,519 | 1,374,576 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 48,999 | 1,325,577 (0%) | 0% | 14.2 | 693,826 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | 06 Mar 2026 | 256,074 | 256,074 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 2,433 | 1,329,326 (0%) | 0% | 14.2 | 34,451 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | 06 Mar 2026 | 124,519 | 249,036 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 06 Mar 2026 | 6,181 | 12,362 | - | - | Dividend Equivalent Units | ||
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 144,873 (0%) | 0% | 0 | Common Stock | |
| Ms. Melina E. Higgins | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Ms. Melina E. Higgins | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Melina E. Higgins | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 146,048 (0%) | 0% | 0 | Common Stock | |
| Mr. Matthew J. Maletta | Chief Legal Officer | 06 Mar 2026 | 59,323 | 59,323 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 102,526 (0%) | 0% | 0 | Common Stock | |
| Dillon JoEllen Lyons | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Dillon JoEllen Lyons | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 101,351 (0%) | 0% | 0 | Common Stock | |
| Dr. Michael Severino, M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 25,112 | 25,112 (0%) | 0% | 0 | Common Stock | |
| Dr. Michael Severino, M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 919 | 26,031 (0%) | 0% | 0 | Common Stock | |
| Dr. Michael Severino, M.D. | Director | 06 Mar 2026 | 25,112 | 0 | - | - | Restricted Stock Units | ||
| Dr. Michael Severino, M.D. | Director | 06 Mar 2026 | 918 | 0 | - | - | Dividend Equivalent Units | ||
| Dr. Michael Severino, M.D. | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 45,351 (0%) | 0% | 0 | Common Stock | |
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 46,526 (0%) | 0% | 0 | Common Stock | |
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 06 Mar 2026 | 56,727 | 56,727 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 06 Mar 2026 | 1,370 | 2,740 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | 06 Mar 2026 | 27,603 | 55,205 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 601 | 387,638 (0%) | 0% | 14.2 | 8,510 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 27,603 | 398,956 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,371 | 388,239 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 12,088 | 386,868 (0%) | 0% | 14.2 | 171,166 | Common Stock |
| Mr. Richard A. Mark, C.P.A. | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 116,145 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard A. Mark, C.P.A. | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 114,970 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 973 | 83,214 (0%) | 0% | 14.2 | 13,778 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 06 Mar 2026 | 2,192 | 4,385 | - | - | Dividend Equivalent Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 06 Mar 2026 | 88,984 | 88,984 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 2,193 | 84,187 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 44,165 | 101,582 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 19,588 | 81,994 (0%) | 0% | 14.2 | 277,366 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 06 Mar 2026 | 44,165 | 88,328 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 1,243 | 62,324 (0%) | 0% | 14.2 | 17,601 | Common Stock |
| Mr. Leo Groothuis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 63,499 (0%) | 0% | 0 | Common Stock | |
| Mr. Leo Groothuis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 62 | 63,437 (0%) | 0% | 14.2 | 878 | Common Stock |
| Mr. Leo Groothuis | Director | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Leo Groothuis | Director | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 63,567 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | 06 Mar 2026 | 41,711 | 83,421 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 1,146 | 70,645 (0%) | 0% | 14.2 | 16,227 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 2,071 | 71,791 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 23,067 | 69,720 (0%) | 0% | 14.2 | 326,629 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 41,711 | 92,787 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | 06 Mar 2026 | 86,017 | 86,017 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | 06 Mar 2026 | 2,070 | 4,141 | - | - | Dividend Equivalent Units | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 415 | 219,677 (0%) | 0% | 14.2 | 5,876 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | 06 Mar 2026 | 19,169 | 38,337 | - | - | Restricted Stock Units | ||
| Mr. Andrew Enrietti | See Remarks | 06 Mar 2026 | 951 | 1,903 | - | - | Dividend Equivalent Units | ||
| Mr. Andrew Enrietti | See Remarks | 06 Mar 2026 | 60,435 | 60,435 | - | - | Restricted Stock Units | ||
| Mr. Andrew Enrietti | See Remarks | 06 Mar 2026 | 19,169 | 227,477 (0%) | 0% | 0 | Common Stock | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 8,337 | 219,140 (0%) | 0% | 14.2 | 118,052 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | 06 Mar 2026 | 952 | 220,092 (0%) | 0% | 0 | Common Stock | ||
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 144,873 (0%) | 0% | 0 | - | |
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 146,048 (0%) | 0% | 0 | - | |
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 164,055 (0%) | 0% | 0 | - | |
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 165,230 (0%) | 0% | 0 | - | |
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 110,869 (0%) | 0% | 0 | - | |
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 112,044 (0%) | 0% | 0 | - | |
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 114,970 (0%) | 0% | 0 | - | |
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 116,145 (0%) | 0% | 0 | - | |
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 101,351 (0%) | 0% | 0 | - | |
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 102,526 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 27,603 | 398,956 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 12,088 | 386,868 (0%) | 0% | 14.2 | 171,166 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,371 | 388,239 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.16 per share. | 06 Mar 2026 | 601 | 387,638 (0%) | 0% | 14.2 | 8,510 | - |
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 160,082 (0%) | 0% | 0 | - | |
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 161,257 (0%) | 0% | 0 | - | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 36,720 | 72,019 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 04 Mar 2026 | 3,053 | 3,053 | - | - | Dividend Equivalent Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 04 Mar 2026 | 36,720 | 36,721 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 04 Mar 2026 | 1,355 | 57,417 (0%) | 0% | 14.7 | 19,932 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 3,053 | 58,772 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 04 Mar 2026 | 16,300 | 55,719 (0%) | 0% | 14.7 | 239,773 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 31,149 | 66,991 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | 04 Mar 2026 | 2,934 | 2,934 | - | - | Dividend Equivalent Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | 04 Mar 2026 | 31,149 | 31,149 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 04 Mar 2026 | 1,624 | 51,076 (0%) | 0% | 14.7 | 23,889 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 2,935 | 52,700 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 04 Mar 2026 | 17,226 | 49,765 (0%) | 0% | 14.7 | 253,394 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 18,154 | 415,340 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 135,828 | 450,635 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 53,449 | 397,186 (0%) | 0% | 14.9 | 795,856 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 7,144 | 408,196 (0%) | 0% | 14.9 | 106,374 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 1,286,849 | 1,695,045 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 506,376 | 1,188,669 (0%) | 0% | 14.9 | 7,539,939 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 92,503 | 1,281,172 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 36,400 | 1,244,772 (0%) | 0% | 14.7 | 535,444 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 8,714 | 1,253,486 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 3,429 | 1,250,057 (0%) | 0% | 14.7 | 50,441 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2026 | 135,828 | 0 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2026 | 18,153 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2026 | 1,286,849 | 1,286,849 | - | - | Performance Restricted Stock Units(11) | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2026 | 1,286,849 | 0 | - | - | Performance Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2026 | 92,503 | 92,503 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2026 | 8,713 | 8,714 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 74,320 | 360,831 (0%) | 0% | 14.9 | 1,106,625 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2026 | 1,611 | 1,611 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2026 | 17,108 | 17,108 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2026 | 169,718 | 0 | - | - | Performance Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2026 | 169,718 | 169,718 | - | - | Performance Restricted Stock Units(11) | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2026 | 2,619 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 169,718 | 435,151 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 1,148 | 265,433 (0%) | 0% | 14.9 | 17,094 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 17,108 | 377,939 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 7,492 | 370,447 (0%) | 0% | 14.7 | 110,207 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 1,612 | 372,059 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 706 | 371,353 (0%) | 0% | 14.7 | 10,385 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2026 | 17,689 | 0 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 2,620 | 266,581 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 7,868 | 263,961 (0%) | 0% | 14.9 | 117,155 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 17,689 | 271,829 (0%) | 0% | 0 | Common Stock | |
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 1,278 | 1,278 | - | - | Dividend Equivalent Units | ||
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 11,531 | 141,531 (0%) | 0% | 0 | Common Stock | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 5,094 | 136,437 (0%) | 0% | 14.9 | 75,850 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 1,709 | 138,146 (0%) | 0% | 0 | Common Stock | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 744 | 137,402 (0%) | 0% | 14.9 | 11,078 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 110,630 | 248,032 (0%) | 0% | 0 | Common Stock | |
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 48,113 | 199,919 (0%) | 0% | 14.9 | 716,403 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 13,568 | 213,487 (0%) | 0% | 0 | Common Stock | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 5,901 | 207,586 (0%) | 0% | 14.7 | 86,804 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 1,279 | 208,865 (0%) | 0% | 0 | Common Stock | ||
| Mr. Andrew Enrietti | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 557 | 208,308 (0%) | 0% | 14.7 | 8,193 | Common Stock |
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 11,531 | 0 | - | - | Restricted Stock Units | ||
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 1,708 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 110,630 | 110,630 | - | - | Performance Restricted Stock Units (11) | ||
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 110,630 | 0 | - | - | Performance Restricted Stock Units | ||
| Mr. Andrew Enrietti | See Remarks | 03 Mar 2026 | 13,568 | 13,569 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 17,689 | 271,829 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 7,868 | 263,961 (0%) | 0% | 14.9 | 117,155 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 2,620 | 266,581 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 1,148 | 265,433 (0%) | 0% | 14.9 | 17,094 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 169,718 | 435,151 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.89 per share. | 03 Mar 2026 | 74,320 | 360,831 (0%) | 0% | 14.9 | 1,106,625 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 17,108 | 377,939 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 7,492 | 370,447 (0%) | 0% | 14.7 | 110,207 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 1,612 | 372,059 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.71 per share. | 03 Mar 2026 | 706 | 371,353 (0%) | 0% | 14.7 | 10,385 | - |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 01 Jan 2026 | 1,203 | 35,842 (0%) | 0% | 12.4 | 14,977 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,175 | 37,045 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 01 Jan 2026 | 13,395 | 34,870 (0%) | 0% | 12.5 | 166,768 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | 01 Jan 2026 | 23,085 | 0 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 23,085 | 48,265 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | 01 Jan 2026 | 2,174 | 0 | - | - | Dividend Equivalent Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.25 per share. | 11 Sep 2025 | 7,032 | 35,299 (0%) | 0% | 10.2 | 72,045 | Common Stock |
| Mr. David S. Simmons | Director | Purchase of securities on an exchange or from another person at price $ 10.42 per share. | 27 Aug 2025 | 286 | 970 (0%) | 0% | 10.4 | 2,981 | Common Stock |
| Mr. David S. Simmons | Director | 27 Aug 2025 | 15,890 | 15,890 | - | - | Restricted Stock Units | ||
| Mr. David S. Simmons | Director | Purchase of securities on an exchange or from another person at price $ 10.43 per share. | 27 Aug 2025 | 213 | 1,183 (0%) | 0% | 10.4 | 2,221 | Common Stock |
| Mr. David S. Simmons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 22,820 | 22,820 (0%) | 0% | 0 | Common Stock | |
| Mr. David S. Simmons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 524 | 23,344 (0%) | 0% | 0 | Common Stock | |
| Mr. David S. Simmons | Director | 27 Aug 2025 | 22,820 | 0 | - | - | Restricted Stock Units | ||
| Mr. David S. Simmons | Director | 27 Aug 2025 | 523 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Andrew Enrietti | See Remarks | 15 Aug 2025 | 75,401 | 75,401 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.99 per share. | 12 Aug 2025 | 22,000 | 314,807 (0%) | 0% | 10.0 | 219,740 | Common Stock |
| Mr. David S. Simmons | Director | 11 Aug 2025 | 22,820 | 22,820 | - | - | Restricted Stock Units | ||
| Dr. Michael Severino, M.D. | Director | 12 May 2025 | 25,112 | 25,112 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.94 per share. | 12 May 2025 | 60,000 | 292,807 (0%) | 0% | 8.9 | 536,262 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 39,344 | 60,441 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.48 per share. | 15 Apr 2025 | 855 | 42,331 (0%) | 0% | 7.5 | 6,395 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 15 Apr 2025 | 39,344 | 39,344 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 15 Apr 2025 | 1,767 | 1,768 | - | - | Dividend Equivalent Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 1,768 | 43,186 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.48 per share. | 15 Apr 2025 | 19,023 | 41,418 (0%) | 0% | 7.5 | 142,292 | Common Stock |
| Ms. Elisha W. Finney | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. Harry A. Korman | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. Mark W. Parrish | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 06 Mar 2025 | 373,555 | 373,555 | - | - | Restricted Stock Units | ||
| Ms. Melina E. Higgins | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 06 Mar 2025 | 82,808 | 82,808 | - | - | Restricted Stock Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 06 Mar 2025 | 132,493 | 132,493 | - | - | Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | 06 Mar 2025 | 93,849 | 93,849 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | 06 Mar 2025 | 125,132 | 125,132 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 31,149 | 41,815 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 17,226 | 24,589 (0%) | 0% | 9.4 | 161,408 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | 04 Mar 2025 | 1,322 | 2,645 | - | - | Dividend Equivalent Units | ||
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 139,622 (0%) | 0% | 0 | - | |
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 140,395 (0%) | 0% | 0 | - | |
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 79,569 (0%) | 0% | 0 | - | |
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 80,342 (0%) | 0% | 0 | - | |
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 135,649 (0%) | 0% | 0 | - | |
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 136,422 (0%) | 0% | 0 | - | |
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 120,440 (0%) | 0% | 0 | - | |
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 121,213 (0%) | 0% | 0 | - | |
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 90,537 (0%) | 0% | 0 | - | |
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 91,310 (0%) | 0% | 0 | - | |
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 76,918 (0%) | 0% | 0 | - | |
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 77,691 (0%) | 0% | 0 | - | |
| Mr. Harry A. Korman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 113,164 (0%) | 0% | 0 | - | |
| Mr. Harry A. Korman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 113,937 (0%) | 0% | 0 | - | |
| Ms. Elisha W. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 37,832 (0%) | 0% | 0 | Common Stock | |
| Ms. Elisha W. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 37,059 (0%) | 0% | 0 | Common Stock | |
| Ms. Elisha W. Finney | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Elisha W. Finney | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. Harry A. Korman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 113,937 (0%) | 0% | 0 | Common Stock | |
| Mr. Harry A. Korman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 113,164 (0%) | 0% | 0 | Common Stock | |
| Mr. Harry A. Korman | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Harry A. Korman | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 135,649 (0%) | 0% | 0 | Common Stock | |
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 136,422 (0%) | 0% | 0 | Common Stock | |
| Mr. James M. Kilts | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 79,569 (0%) | 0% | 0 | Common Stock | |
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 80,342 (0%) | 0% | 0 | Common Stock | |
| Mr. Wyllie Don Cornwell | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 139,622 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Mark W. Parrish | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 140,395 (0%) | 0% | 0 | Common Stock | |
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 121,213 (0%) | 0% | 0 | Common Stock | |
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 120,440 (0%) | 0% | 0 | Common Stock | |
| Ms. Melina E. Higgins | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Melina E. Higgins | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Dillon JoEllen Lyons | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 77,691 (0%) | 0% | 0 | Common Stock | |
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 76,918 (0%) | 0% | 0 | Common Stock | |
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 21,267 | 21,267 (0%) | 0% | 0 | Common Stock | |
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 04 Mar 2025 | 423 | 0 | - | - | Dividend Equivalent Units | ||
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 04 Mar 2025 | 21,267 | 0 | - | - | Restricted Stock Units | ||
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 424 | 21,691 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard A. Mark, C.P.A. | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 91,310 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 90,537 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 1,173 | 21,618 (0%) | 0% | 0 | Common Stock | |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 16,276 | 20,445 (0%) | 0% | 9.4 | 152,506 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 04 Mar 2025 | 36,721 | 73,441 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 04 Mar 2025 | 1,172 | 2,344 | - | - | Dividend Equivalent Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 521 | 21,097 (0%) | 0% | 9.4 | 4,882 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 36,721 | 36,721 (0%) | 0% | 0 | Common Stock | |
| Mr. Leo Groothuis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 18,204 | 40,350 (0%) | 0% | 0 | Common Stock | |
| Mr. Leo Groothuis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 1,166 | 39,184 (0%) | 0% | 9.4 | 10,925 | Common Stock |
| Mr. Leo Groothuis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 773 | 39,957 (0%) | 0% | 0 | Common Stock | |
| Mr. Leo Groothuis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 04 Mar 2025 | 50 | 39,907 (0%) | 0% | 9.4 | 469 | Common Stock |
| Mr. Leo Groothuis | Director | 04 Mar 2025 | 18,204 | 0 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | 04 Mar 2025 | 772 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 1,323 | 25,912 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 04 Mar 2025 | 732 | 25,180 (0%) | 0% | 9.4 | 6,859 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | 04 Mar 2025 | 31,149 | 62,298 | - | - | Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 10,961 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 82,353 | 0 | - | - | Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 7,668 | 7,668 | - | - | Dividend Equivalent Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 81,761 | 81,761 | - | - | Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 339,153 | 1,068,262 (0%) | 0% | 9.4 | 3,177,864 | Common Stock |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 779,841 | 1,407,415 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 602 | 627,574 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 18,845 | 626,972 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,962 | 612,895 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 4,768 | 608,127 (0%) | 0% | 9.4 | 44,676 | Common Stock |
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 779,841 | 0 | - | - | Performance Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 779,841 | 779,841 | - | - | Performance Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 601 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Rajiv Malik | Director | 03 Mar 2025 | 18,845 | 0 | - | - | Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 81,761 | 587,599 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 36,536 | 551,063 (0%) | 0% | 9.3 | 340,881 | Common Stock |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 7,669 | 558,732 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 3,336 | 555,396 (0%) | 0% | 9.3 | 31,125 | Common Stock |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 82,353 | 637,749 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 35,816 | 601,933 (0%) | 0% | 9.4 | 335,596 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 1,546 | 232,807 (0%) | 0% | 9.4 | 14,486 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 135,828 | 221,178 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 53,449 | 167,729 (0%) | 0% | 9.3 | 498,679 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,872 | 178,601 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 4,279 | 174,322 (0%) | 0% | 9.3 | 39,923 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 92,503 | 266,825 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 36,400 | 230,425 (0%) | 0% | 9.4 | 341,068 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2025 | 135,828 | 135,828 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2025 | 3,927 | 7,854 | - | - | Dividend Equivalent Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2025 | 92,503 | 185,006 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2025 | 10,871 | 10,871 | - | - | Dividend Equivalent Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 3,928 | 234,353 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 17,689 | 17,689 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 169,238 | 0 | - | - | Performance Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,689 | 144,590 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 7,916 | 136,674 (0%) | 0% | 9.3 | 73,856 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,659 | 138,333 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 727 | 137,606 (0%) | 0% | 9.3 | 6,783 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,872 | 155,478 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 7,827 | 147,651 (0%) | 0% | 9.4 | 73,339 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 2,379 | 150,030 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 1,042 | 148,988 (0%) | 0% | 9.4 | 9,764 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,109 | 166,097 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 7,493 | 158,604 (0%) | 0% | 9.4 | 70,209 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 727 | 159,331 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 319 | 159,012 (0%) | 0% | 9.4 | 2,989 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 169,238 | 328,250 (0%) | 0% | 0 | Common Stock | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 74,110 | 254,140 (0%) | 0% | 9.4 | 694,411 | Common Stock |
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 1,658 | 1,659 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 17,872 | 0 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 2,378 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 17,109 | 34,216 | - | - | Restricted Stock Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 726 | 1,452 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | 03 Mar 2025 | 169,238 | 169,238 | - | - | Performance Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,574 | 78,669 (0%) | 0% | 0 | Common Stock | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 1,001 | 88,905 (0%) | 0% | 9.4 | 9,379 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 2,284 | 89,906 (0%) | 0% | 0 | Common Stock | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 7,514 | 87,622 (0%) | 0% | 9.4 | 70,406 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,157 | 95,136 (0%) | 0% | 0 | Common Stock | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 690 | 77,979 (0%) | 0% | 9.3 | 6,438 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 7,399 | 77,095 (0%) | 0% | 9.3 | 69,033 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 16,771 | 84,494 (0%) | 0% | 0 | Common Stock | |
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 1,573 | 1,573 | - | - | Dividend Equivalent Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 17,157 | 0 | - | - | Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 2,283 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 23,362 | 46,723 | - | - | Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 991 | 1,984 | - | - | Dividend Equivalent Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 162,468 | 162,468 | - | - | Performance Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 162,468 | 0 | - | - | Performance Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | 03 Mar 2025 | 16,771 | 16,772 | - | - | Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 71,145 | 193,916 (0%) | 0% | 9.4 | 666,629 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 162,468 | 265,061 (0%) | 0% | 0 | Common Stock | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 435 | 102,593 (0%) | 0% | 9.4 | 4,076 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 992 | 103,028 (0%) | 0% | 0 | Common Stock | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 10,231 | 102,036 (0%) | 0% | 9.4 | 95,864 | Common Stock |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 23,362 | 112,267 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 81,761 | 587,599 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 36,536 | 551,063 (0%) | 0% | 9.3 | 340,881 | - |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 7,669 | 558,732 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 3,336 | 555,396 (0%) | 0% | 9.3 | 31,125 | - |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 82,353 | 637,749 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 35,816 | 601,933 (0%) | 0% | 9.4 | 335,596 | - |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,962 | 612,895 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 4,768 | 608,127 (0%) | 0% | 9.4 | 44,676 | - |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 18,845 | 626,972 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 602 | 627,574 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 779,841 | 1,407,415 (0%) | 0% | 0 | - | |
| Mr. Rajiv Malik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 339,153 | 1,068,262 (0%) | 0% | 9.4 | 3,177,864 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 16,771 | 84,494 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 7,399 | 77,095 (0%) | 0% | 9.3 | 69,033 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,574 | 78,669 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 690 | 77,979 (0%) | 0% | 9.3 | 6,438 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,157 | 95,136 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 7,514 | 87,622 (0%) | 0% | 9.4 | 70,406 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 2,284 | 89,906 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 1,001 | 88,905 (0%) | 0% | 9.4 | 9,379 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 23,362 | 112,267 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 10,231 | 102,036 (0%) | 0% | 9.4 | 95,864 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 992 | 103,028 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 435 | 102,593 (0%) | 0% | 9.4 | 4,076 | - |
| Mr. Brian Roman | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 162,468 | 265,061 (0%) | 0% | 0 | - | |
| Mr. Brian Roman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 71,145 | 193,916 (0%) | 0% | 9.4 | 666,629 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,689 | 144,590 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 7,916 | 136,674 (0%) | 0% | 9.3 | 73,856 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,659 | 138,333 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 727 | 137,606 (0%) | 0% | 9.3 | 6,783 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,872 | 155,478 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 7,827 | 147,651 (0%) | 0% | 9.4 | 73,339 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 2,379 | 150,030 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 1,042 | 148,988 (0%) | 0% | 9.4 | 9,764 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 17,109 | 166,097 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 7,493 | 158,604 (0%) | 0% | 9.4 | 70,209 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 727 | 159,331 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 319 | 159,012 (0%) | 0% | 9.4 | 2,989 | - |
| Mr. Paul B. Campbell | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 169,238 | 328,250 (0%) | 0% | 0 | - | |
| Mr. Paul B. Campbell | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 74,110 | 254,140 (0%) | 0% | 9.4 | 694,411 | - |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 23,084 | 23,084 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 01 Jan 2025 | 12,876 | 10,208 (0%) | 0% | 12.4 | 160,306 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 981 | 11,189 (0%) | 0% | 0 | Common Stock | |
| Ms. Theodora Mistras | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 01 Jan 2025 | 523 | 10,666 (0%) | 0% | 12.4 | 6,511 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | 01 Jan 2025 | 23,084 | 23,085 | - | - | Restricted Stock Units | ||
| Ms. Theodora Mistras | Chief Financial Officer | 01 Jan 2025 | 980 | 980 | - | - | Dividend Equivalent Units | ||
| Mr. Paul B. Campbell | See Remarks | Sale of securities on an exchange or to another person at price $ 12.88 per share. | 11 Nov 2024 | 26,925 | 126,901 (0%) | 0% | 12.9 | 346,686 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 11.71 per share. | 12 Sep 2024 | 60,319 | 0 (0%) | 0% | 11.7 | 706,553 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 11.66 per share. | 12 Sep 2024 | 139,681 | 505,838 (0%) | 0% | 11.7 | 1,628,164 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 11.90 per share. | 28 Aug 2024 | 50,000 | 110,319 (0%) | 0% | 11.9 | 595,075 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 28 Aug 2024 | 50,000 | 60,319 (0%) | 0% | 12 | 600,000 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 11.75 per share. | 21 Aug 2024 | 100,000 | 360,319 (0%) | 0% | 11.8 | 1,175,260 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 11.73 per share. | 21 Aug 2024 | 100,000 | 260,319 (0%) | 0% | 11.7 | 1,172,630 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 11.75 per share. | 21 Aug 2024 | 100,000 | 160,319 (0%) | 0% | 11.8 | 1,175,100 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 10.52 per share. | 13 Jun 2024 | 85,660 | 909,819 (0%) | 0% | 10.5 | 900,741 | Common Stock |
| Mr. Rajiv Malik | Director | Sale of securities on an exchange or to another person at price $ 10.18 per share. | 13 Jun 2024 | 264,300 | 645,519 (0%) | 0% | 10.2 | 2,690,283 | Common Stock |
| Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. | Director | 03 Jun 2024 | 21,267 | 21,267 | - | - | Restricted Stock Units | ||
| Mr. Brian Roman | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.38 per share. | 28 May 2024 | 89,419 | 67,723 (0%) | 0% | 10.4 | 928,429 | Common Stock |
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 18 Apr 2024 | 78,688 | 78,688 | - | - | Restricted Stock Units | ||
| Dr. Corinne Le Goff, Pharm.D. | Chief Commercial Officer | 18 Apr 2024 | 110,162 | 110,162 | - | - | Restricted Stock Units | ||
| Mr. Rajiv Malik | Director | 02 Apr 2024 | 18,845 | 18,845 | - | - | Restricted Stock Units | ||
| Mr. Anthony Mauro | See Remarks | Sale of securities on an exchange or to another person at price $ 12.09 per share. | 13 Mar 2024 | 250,000 | 243,044 (0%) | 0% | 12.1 | 3,023,700 | Common Stock |
| Ms. Theodora Mistras | Chief Financial Officer | 04 Mar 2024 | 93,447 | 93,447 | - | - | Restricted Stock Units | ||
| Ms. Elisha W. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 17,970 (0%) | 0% | 0 | Common Stock | |
| Ms. Elisha W. Finney | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Ms. Elisha W. Finney | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Elisha W. Finney | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Ms. Elisha W. Finney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 18,855 (0%) | 0% | 0 | Common Stock | |
| Mr. Harry A. Korman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 89,806 (0%) | 0% | 0 | Common Stock | |
| Mr. Harry A. Korman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 88,921 (0%) | 0% | 0 | Common Stock | |
| Mr. Harry A. Korman | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Mr. Harry A. Korman | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Harry A. Korman | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 116,560 (0%) | 0% | 0 | Common Stock | |
| Mr. James M. Kilts | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. James M. Kilts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 117,445 (0%) | 0% | 0 | Common Stock | |
| Mr. James M. Kilts | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Mr. James M. Kilts | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 61,365 (0%) | 0% | 0 | Common Stock | |
| Mr. Wyllie Don Cornwell | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Wyllie Don Cornwell | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Mr. Wyllie Don Cornwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 60,480 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 120,533 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 121,418 (0%) | 0% | 0 | Common Stock | |
| Mr. Mark W. Parrish | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Mr. Mark W. Parrish | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 03 Mar 2024 | 53,449 | 82,380 (0%) | 0% | 12.6 | 672,923 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 135,829 | 135,829 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 4,898 | 87,278 (0%) | 0% | 0 | Common Stock | |
| Mr. Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 03 Mar 2024 | 1,928 | 85,350 (0%) | 0% | 12.6 | 24,274 | Common Stock |
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2024 | 135,829 | 271,656 | - | - | Restricted Stock Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2024 | 4,897 | 9,794 | - | - | Dividend Equivalent Units | ||
| Mr. Scott A. Smith | Director, Chief Executive Officer | 03 Mar 2024 | 277,509 | 277,509 | - | - | Restricted Stock Units | ||
| Ms. Melina E. Higgins | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Ms. Melina E. Higgins | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 101,351 (0%) | 0% | 0 | Common Stock | |
| Ms. Melina E. Higgins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 102,236 (0%) | 0% | 0 | Common Stock | |
| Ms. Melina E. Higgins | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Dillon JoEllen Lyons | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 77,829 (0%) | 0% | 0 | Common Stock | |
| Dillon JoEllen Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 78,714 (0%) | 0% | 0 | Common Stock | |
| Dillon JoEllen Lyons | Director | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 03 Mar 2024 | 20,000 | 58,714 (0%) | 0% | 12.4 | 247,200 | Common Stock |
| Dillon JoEllen Lyons | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 17,970 | 71,448 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard A. Mark, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 885 | 72,333 (0%) | 0% | 0 | Common Stock | |
| Mr. Richard A. Mark, C.P.A. | Director | 03 Mar 2024 | 17,970 | 0 | - | - | Restricted Stock Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | 03 Mar 2024 | 884 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Richard A. Mark, C.P.A. | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 530 | 22,154 (0%) | 0% | 0 | Common Stock | |
| Mr. Leo Groothuis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 21,954 | 21,954 (0%) | 0% | 0 | Common Stock | |
| Mr. Leo Groothuis | Director | 03 Mar 2024 | 18,204 | 18,204 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | 03 Mar 2024 | 529 | 0 | - | - | Dividend Equivalent Units | ||
| Mr. Leo Groothuis | Director | 03 Mar 2024 | 21,954 | 0 | - | - | Restricted Stock Units | ||
| Mr. Leo Groothuis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.62 per share. | 03 Mar 2024 | 8 | 22,146 (0%) | 0% | 12.6 | 101 | Common Stock |
| Mr. Leo Groothuis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 03 Mar 2024 | 330 | 21,624 (0%) | 0% | 12.6 | 4,155 | Common Stock |
| Mr. Rajiv Malik | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 8,883 | 900,282 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 357,353 | 1,008,849 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 02 Mar 2024 | 155,413 | 853,436 (0%) | 0% | 12.6 | 1,956,650 | Common Stock |
| Mr. Rajiv Malik | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 67,180 | 920,616 (0%) | 0% | 0 | Common Stock | |
| Mr. Rajiv Malik | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 02 Mar 2024 | 29,217 | 891,399 (0%) | 0% | 12.6 | 367,842 | Common Stock |
| Mr. Rajiv Malik | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 02 Mar 2024 | 3,864 | 896,418 (0%) | 0% | 12.6 | 48,648 | Common Stock |